Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
McKinsey
Johnson and Johnson
Express Scripts
Baxter

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,025,290

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,025,290
Title:Generation of therapeutic microfoam
Abstract: Improved therapeutic sclerosing microfoams are provided that have advantage in producing a consistent profile injectable foam with minimal input by the physician yet using high volume percentages of blood dispersible gases, thus avoiding use of potentially hazardous amounts of nitrogen.
Inventor(s): Osman; Tariq (London, GB), Harman; Anthony David (Checkendon, GB), Boorman; Timothy David (Frinton on Sea, GB), Flynn; Sheila Bronwen (Nr. Stevenage, GB), Wright; David Dakin Iorwerth (High Wycombe, GB)
Assignee: BTG International Limited (London, GB)
Application Number:10/300,758
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Device; Delivery;

Drugs Protected by US Patent 7,025,290

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Provensis VARITHENA polidocanol SOLUTION;INTRAVENOUS 205098-001 Nov 25, 2013 RX Yes Yes   Start Trial   Start Trial Y A METHOD OF GENERATING AN INJECTABLE FOAM OF CONTROLLED DENSITY AND BUBBLE SIZE   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,025,290

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9912356May 26, 1999
United KingdomPCT/GB00/02045May 26, 2000

International Family Members for US Patent 7,025,290

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 025530   Start Trial
Argentina 027175   Start Trial
Argentina 089412   Start Trial
Austria 313317   Start Trial
Austria 338807   Start Trial
Australia 2005205772   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Mallinckrodt
Dow
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.